{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69612d9223ce58f14619a8f6/69612dd923ce58f14619bf3c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The AstraZeneca Saga","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69612d9223ce58f14619a8f6/2974c295e31b514784c57c3bf9738389.jpg?height=200","description":"<p>Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. </p><p><br></p><p>By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?</p><p><br></p><p><strong>Guest: </strong></p><p> </p><p><a href=\"https://twitter.com/paldhous?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Peter Aldhous</a>, science reporter at Buzzfeed News</p><p><br></p><p><strong>Host</strong></p><p>Lizzie O’Leary</p><p> </p><p> </p>","author_name":"Slate Podcasts"}